Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blink Contacts Lubricating Eye Drops is an isotonic artificial tear solution formulated to alleviate symptoms of dry eye and ocular irritation, particularly in contact lens wearers. The product contains polyethylene glycol 400 as a primary lubricant and sodium hyaluronate as a hydration booster. Sodium hyaluronate works by binding water to the ocular surface, which helps to maintain hydration and potentially reduce tear film hyperosmolarity—a key factor in dry eye syndrome. The solution also includes essential electrolytes (sodium, potassium, calcium, and magnesium) to mimic the composition of natural tears and is preserved with a stabilized oxychloro complex. Clinical research led by Dr. Thomas O. Salmon has specifically investigated the product's efficacy in restoring osmotic balance in the tear film.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Blink Contacts Lubricating Eye Drops.